CONMED Corporation vs. Neuraxis, Inc.
CONMED Corporation and Neuraxis, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| CNMD | NRXS | |
|---|---|---|
| Market Cap | $1.37 billion | $89.54 million |
CNMD leads on 1 of 1 size & scale factors.
Dividend
| CNMD | NRXS | |
|---|---|---|
| Dividend Yield | 1.75% | — |
CNMD and NRXS split the dividend factors evenly.
Risk & Sentiment
| CNMD | NRXS | |
|---|---|---|
| Short Interest | 2.50% | 0.02% |
NRXS leads on 1 of 1 risk & sentiment factors.
Dig deeper: CNMD overview, CNMD financials, NRXS overview, NRXS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
